Reprogramming Immune Response With Capsid-Optimized AAV6 Vectors for Immunotherapy of Cancer
Journal of immunotherapy (Hagerstown, Md. : 1997) - United States
doi 10.1097/cji.0000000000000093
Full Text
Open PDFAbstract
Available in full text
Date
September 1, 2015
Authors
Publisher
Ovid Technologies (Wolters Kluwer Health)